Are members required to be enrolled in a comprehensive weight loss program prior to or concurrently with receiving the medication
Cardiovascular disease risk factors in women: the impact of race and ethnicity: a scientific statement from the American Heart Association
Over time, pharmacological engineering enabled: Short-acting injectables (e.g., exenatide) Long-acting once-weekly injectables (liraglutide, semaglutide) Multi-target incretin therapies (tirzepatide) Oral peptide formulations and now oral small molecules The most recent breakthrough is the development of orally available GLP-1 receptor agonists, including: Orforglipron (Lilly) Elecoglipron (AstraZeneca) These compounds eliminate the need for injection and could dramatically expand accessibility and adherence in obesity and diabetes populations
The Obstetric Emergency Department allows us to respond quickly, provide clarity and help families feel supported from the moment they walk through the door. NICU Wellstar Cobb is home to a Level III NICU providing advanced care for premature and medically complex newborns
Healthcare professionals can choose between GLP-1 RAs and SGLT2Is in T2D patients with high CV risks
So obesity is a disease and it is a chronic disease